Levi A, et al. - This study investigated predictors of 1-year mortality in post-Transcatheter Aortic Valve Implantation (TAVI) patients stratified by the presence or absence of advanced chronic kidney disease (CKD) (defined as eGFR ≤ 30 ml/min/1.73m² or permanent renal replacement therapy). Findings demonstrated an incremental impact of the coexistence of advanced CKD and either reduced Left Ventricular Ejection Fraction (LVEF) or poor functional class (FC) on the risk of death post- TAVI. In contrast, in patients without advanced CKD, bleeding had a greater effect on risk of death.